mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.8 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.08 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.08 |